NEW YORK (Reuters) - The U.S. Treasury Department proposed new tax regulations late on Monday threw a series of proposed mergers into question, including Pfizer Inc's $160 billion agreement to buy Allergan Plc , causing Allergan shares to fall sharply.
Read more
No comments:
Post a Comment